The role of oral vitamin K antagonists in the outcome of infrainguinal bypass procedures

Angiology. 2014 Aug;65(7):568-73. doi: 10.1177/0003319713499816. Epub 2013 Sep 3.

Abstract

We investigated the role of oral vitamin K antagonists (VKAs) in graft patency, limb salvage, major and minor bleeding rates in patients undergoing infrainguinal bypass surgery. Five randomized-controlled trials (RCTs; n = 3746 patients) comparing VKA versus non-VKA treatment outcomes in patients undergoing infrainguinal bypass surgery were analyzed. The VKA treatment was associated with improved graft patency rates when a vein graft was used (risk ratio [RR]: 0.74; P = .0004), while there was no difference with prosthetic grafts (RR: 1.07; P = .39). The VKA treatment was also associated with improved limb salvage rates (RR: 0.33; P = .0008). Major and minor bleeding complications were higher in the VKA group. In conclusion, VKA treatment is associated with improved graft patency and limb salvage rates when a vein graft is used at the price of an increased risk of bleeding. Due to the inconsistent results, further well-designed RCTs are needed.

Keywords: antiplatelet agents; coumadin; graft patency; infrainguinal bypass; peripheral arterial disease; vitamin K antagonists; warfarin.

Publication types

  • Review

MeSH terms

  • Administration, Oral
  • Fibrinolytic Agents / administration & dosage
  • Fibrinolytic Agents / adverse effects
  • Fibrinolytic Agents / therapeutic use
  • Graft Occlusion, Vascular / drug therapy
  • Humans
  • Randomized Controlled Trials as Topic
  • Treatment Outcome
  • Vascular Grafting*
  • Vascular Patency / drug effects*
  • Vitamin K / antagonists & inhibitors*

Substances

  • Fibrinolytic Agents
  • Vitamin K